Cannabis Beverages: 4 Stocks That Could Dominate the Space
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) — Mugglehead believes the cannabis industry will look very different a year from now. By next year, edibles – including beverages – will likely be one of the biggest sellers in retail outlets, just as they are south of the border. Meanwhile, with hemp-derived cannabidiol (CBD) now being permitted federally, the U.S. market could also see a whole new wave of cannabis products.
And that means this year could be a big one for cannabis edibles and beverages. So there’s no better time than the present for a primer on some of the bigger names in the space. Here are some of the biggest, including one with a massive brand that just received endorsement from an NFL legend.
Tilray Inc (NASDAQ:TLRY)
One of the biggest stocks in the space, Tilray is looking to make a big splash in the beverages market. In December, we learned that it would be working with Anheuser-Busch InBev SA in what’s being called a “research partnership.” While it’s not exactly a firm partnership or even a guarantee that the two will sell or co-brand products, it’s a joint project that will benefit both companies and bring them closer to deciding on a strategy for the beverages market.
Tilray just announced some big changes to its leadership team – adding a full squad of personnel with strong pedigrees in the beverage space. Just take a look:
- Charlie Cain will serve as VP of Retail. Previously, he was the VP of Concept Development and Franchising for Starbucks Corporation. He’s been involved with retail strategy for over 15 years and has had some exposure to the cannabis industry already.
- Rita Seguin is the new Executive VP of Human Resources. She’s well connected in the beverage industry having worked with Diageo and will be an integral part in ensuring the right people are in place to help Tilray’s brand continue to grow.
- Greg Christopher will be the Executive VP of Operations and comes from Nestle where he oversaw the supply chain operations in Canada.
- Dara Redler was added as General Counsel for Tilray. She has experience working in senior leadership positions with The Coca-Cola Company
Clearly, it’s a new team stacked with experience in the beverage space. With the recent passing of the U.S Farm Bill, and if their recent management additions are any indication, we suspect Tilray is now on an aggressive path to pursue the beverages market.
Alkaline Water Company Inc (TSX-V:WTER) (NASDAQ:WTER)
How can we talk about the beverage space without talking about one of the more advanced beverage companies entering the CBD beverage space. While a smaller company overall, Alkaline has some big advantages over the other companies on this list.
For one, the Alkaline Water Company is truly a beverage company. Its core product, Alkaline88® is now sold in over 47,500 retail locations nationwide in all 50 states, with a distribution that spans more than 150,000 stores. These include 9 of the top 10 largest retailers in the entire U.S. and two of the largest retailers in the entire world.
Its popular Alkaline88 products are already very well-known among consumers and have been associated with many health benefits already.
In fact, former NFL star Michael Irvin has used the product and vouches for its effectiveness. Recently, on CBS, he made some very strong endorsements for Akaline’s product, calling Alkaline88 a ‘lifesaver.’ He went on to say that:
“Alkaline88, the best water. the best way to help you take better care of yourself. It’s not just good to you, this is good for you.”
Struggling with problems relating to acidity in his stomach, Irvin has turned to Alkaline88 to help get some relief, which he says has been a life-saver – adding credibility to Alkaline’s products as The Company has already made a clear connection in the minds of consumers with being healthy and good for their bodies.
Over the past year, the Alkaline Water Company has been working on the development of a CBD-infused hemp water and it could be one of the first national U.S. beverage companies to bring true water-soluble, full-spectrum features of bioactive natural hemp extract molecules to U.S. consumers.
One of the biggest challenges when it comes to infusing beverages with CBD, or hemp, is maintaining efficacy.
But Alkaline Water Company has already secured a deal that brings a patent-pending process that can bring true water-soluble, full-spectrum features of bioactive natural hemp extract molecules to U.S. consumers.
Via Alkaline Water Company:
“The Alkaline Water Company Inc. has entered into a Binding Letter of Agreement with Infusion Biosciences, Inc., that provides a non-exclusive license to utilize its proprietary Aqueous Phytorecovery Process (“APP”) technology.
Under the Agreement, IBS agreed to provide A88 Infused with ready-to-drink natural hemp-extract formulations.”
With APP’s formulations, A88 Infused is expected to be the first national U.S. beverage company– and the first NASDAQ-listed company – to bring true water-soluble, full-spectrum features of bioactive natural hemp extract molecules to U.S. consumers.
With an already widely popular healthful water brand, adding CBD and hemp into their portfolio of beverages could make the Alkaline Water Company even more popular among health-conscious consumers. With a strong presence in the U.S. already, it looks to be in the pole position once the CBD beverages market takes off – especially since its core business is beverages, unlike many of the other cannabis companies.
Hexo Corp (TSX:HEXO)
After securing a deal with Molson Coors Canada (TSX:TPX-B.TO) (NYSE:TAP) last year to produce beverages, Hexo is looking to be one of the big players in the industry as well. Truss is the name of the joint venture the two companies have formed that will be developing the beverages. While we’ve learned little of their progress, Molson CEO Mark Hunter said at last quarter’s earnings that:
The Company is positioning itself to ramp up supply as it is working on a one million square foot greenhouse, which in December Hexo said was both on schedule and on budget. The increase in capacity will be vital in growing more cannabis and freeing up resources to focus on many different marijuana products.
The Company is also working to legitimize itself south of the border. In January, Hexo began trading on the NYSE American exchange – formerly the AMEX – under the ticker symbol ‘HEXO.’
Canopy Growth Corp (TSX:WEED)(NYSE:CGC)
It’s impossible to talk about beverages and not mention one of the leaders in the space, Canopy Growth. The cannabis company put beverages on the radar when it announced a big investment from Constellation Brands, Inc., one of the largest distributors of beer in the world. Recently, Constellation Brands increased its investment in Canopy Growth, with an option to take a controlling interest.
There are some big advantages that Canopy Growth will get from this partnership. Not only will it be able to tap into Constellation’s expertise, but its vast distribution network as well. If cannabis gets legalized in the U.S., Canopy Growth will have a big advantage over its peers as a result.
Furthermore, Canopy Growth just received a license in the State of New York to produce hemp earlier this year. This would open the door for any hemp-based beverages to be sold in the State.
Although the passing of the U.S. Farm Bill opened a big door for the industry, individual States still have to have their plans for regulating and licensing hemp approved by the U.S. Department of Agriculture.
As a result, it may take some time before we see any hemp-based beverages hitting store shelves, but the starting line is definitely within sight.
Directors of Mugglehead own shares of the Alkaline Water Company (WTER) at the time of this writing.
Mugglehead.com is a digital publisher dedicated to cannabis news, investments, culture, and science, owned by Mugglehead Media Corp. We publish original content, including video, interviews and articles. Because many of the companies and trends we cover are related to investments and stocks within the cannabis industry, please review our disclaimer and forward-looking statements below.
Original content created by Mugglehead Media Corp. © 2019 is protected by copyright laws.
We have lots in store for 2019 so be sure to check us out!
Visit us at https://mugglehead.com daily for all things cannabis-related.
Disclaimer and Forward-Looking Statements
Mugglehead Media Corp. and Mugglehead.com (collectively, Mugglehead) is a news and media publisher dedicated to cannabis. It is not registered as an investment adviser, broker-dealer or other financial or securities professional with any financial or securities regulatory authority. You understand that no content published by Mugglehead constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Mugglehead does not render general or specific investment advice and does not endorse or recommend the business, products, services or securities of any industry or company mentioned on this Site.
It is not intended to provide tax, legal, insurance or investment advice, and nothing on the Site should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation to buy or sell any security. None of the content we publish is provided with a view to inviting, inducing or encouraging any person to make any kind of investment decision. You are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should consult an attorney or tax professional regarding your specific legal or tax situation. You should also consult a licensed professional, such as a financial advisor or broker-dealer, when dealing in any securities or making any investment decisions. We do not guarantee that any of the companies mentioned on Mugglehead.com or any of our newsletters or content will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.
This news release is not an offer to sell or a solicitation of an offer to buy any securities or commodities. To the extent that anything in this press release may be deemed to be investment advice or a recommendation in connection with a particular company or security, such information is impersonal and is not tailored to the needs of any specific person.
You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Site will not contain a list or description of relevant risk factors. In addition, some of the securities about which content is published by us have a low market capitalization, insufficient public float and/or are thinly traded. Such securities are subject to more risk than securities of larger companies, including greater volatility, lower liquidity and less publicly available information. Content we publish may have an effect on the price of such securities.
From time to time, Mugglehead (on behalf of itself and any partner, director, officer or insider of Mugglehead) may have a financial or other interest in the party or parties featured on the Site, within the meaning of National Instrument 31-103 – Registration Requirements, Exemptions, and Ongoing Registrant Obligations, published by the Canadian Securities Administrators, as a result of ownership of securities in, compensation received or receivable from or other financial arrangement with such party or parties featured in this press release. We will disclose if we have a position in any such party or parties, as at the date of publication of this press release; however, we may not update this disclosure after such date.
In addition to historical information, this press release may contain forward-looking statements, including statements with respect to third parties regarding product plans, future growth, market opportunities, strategic initiatives, industry positioning, customer acquisition, the amount of recurring revenue and revenue growth. In addition, when used on the Site, the words ”will,” ”expects,” ”could,” ”would,” ”may,” ”anticipates,” ”intends,” ”plans,” ”believes,” ”seeks,” ”targets,” ”estimates,” ”looks for,” ”looks to,” ”continues” and similar expressions, as well as statements regarding a third party’s focus for the future, are generally intended to identify forward-looking statements. Each of the forward-looking statements we make in this press release involves risks and uncertainties that may cause actual results to differ materially from these forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those disclosed by the companies featured in this release in their public securities filings. You should carefully review the risks described therein. You should not place undue reliance on these forward-looking statements, which speak only as of the date such statement was published. Mugglehead undertakes no obligation to publicly release any updates or revisions to the forward-looking statements or reflect events or circumstances after the date of their publication, except as required by law.
From time to time, reference may be made in this press release to prior articles or opinions we have published. These references may be selective, may reference only a portion of an article or opinion, and are likely not to be current. As market information changes continuously, previously published information and data, and any references thereto, may not be current and should not be relied upon.
If you ever have any questions or concerns about our business or publications, we encourage you to contact us.
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) — Mugglehead believes the cannabis industry will look very different a year from now. By…
Top Marijuana Beverage Stocks to Buy in 2019
Take a sip of these stocks to profit from the burgeoning marijuana beverage market.
“This bud’s for you” is about to take on an entirely new meaning.
Companies have made aggressive moves to get into position for what could be a $600 million market in the U.S. by 2022, according to investment firm Canaccord Genuity, and an even larger market worldwide. What’s this significant new market? Cannabis-infused beverages. And 2019 is poised to be a pivotal year for the cannabis-infused-beverage market.
Investors seeking to profit from the early growth of this new opportunity have plenty of options to choose from. But some stocks have a definite head start over others. Here are the top marijuana beverage stocks to buy in 2019 — and what you need to know about the market that’s in its infancy but could soon take off.
Image source: Getty Images.
Types of marijuana beverages
Marijuana beverages go well beyond just dropping a marijuana leaf into a drink. To understand the possibilities for marijuana beverages, it’s important to know something about the two key chemical ingredients in the cannabis plant.
Perhaps the best-known chemical ingredient of cannabis is tetrahydrocannabinol. THC is the primary psychoactive component of cannabis. When marijuana users get high, it’s the result of THC’s effects on their brain.
Another cannabis ingredient that’s also attracted a lot of attention is cannabidiol. Unlike THC, CBD isn’t psychoactive. A CBD-based drug that treats epilepsy, Epidiolex, won approval from the U.S. Food and Drug Administration in June 2018, becoming the first drug made from the marijuana plant to receive an FDA green light. CBD could also potentially be effective in treating neurologic indications including anxiety, inflammation, and pain relief.
These two ingredients highlight the two primary types of marijuana beverages. THC-infused drinks are similar to alcoholic beverages. Their purpose is to give the consumer a buzz. CBD-infused drinks, on the other hand, are intended to be therapeutic. For example, some energy drinks contain CBD. Companies also market CBD-infused “wellness beverages” that purport to ease inflammation and pain.
Marijuana beverages overlap with existing beverage categories as well. Flavored water, coffee, tea, beer, and other alcoholic drinks are starting to include THC and/or CBD.
Dynamics of the marijuana beverage industry
The main thing to know about the marijuana beverage industry is that it’s still in a very early stage, primarily because recreational use of marijuana isn’t legal in most of the world. Currently, only two countries have legalized recreational marijuana at the national level — Uruguay and Canada.
But Canada’s legal recreational marijuana market, which opened in October 2018, doesn’t allow marijuana beverages. The country still hasn’t finalized regulations pertaining to cannabis edibles — including beverages — and concentrates. Health Canada, the agency responsible for Canada’s public health, thought more time was needed “for the development of specific regulations to address the unique risks posed by these product classes.” These regulations are expected to be in place in 2019, opening up what could be a significant new market.
While federal laws in the U.S. prohibit all marijuana use, 10 states plus the District of Columbia have legalized recreational marijuana use. However, in key states including California and Colorado, cannabis-infused beverage sales make up barely 1% of the total legal marijuana market.
But 2019 could be a pivotal year for the marijuana beverage industry in the United States. The results of the November 2018 U.S. elections improve the chances that federal laws could be changed to leave marijuana legalization to the individual states.
Also, the U.S. Congress recently passed legislation that will legalize hemp as an agricultural crop. Hemp by definition is cannabis with no more than 0.3% concentration of THC on a dry-weight basis. Hemp — and by extension CBD-infused beverages where the CBD is derived from hemp — will now be legal in the U.S., opening up a market that could reach $22 billion by 2022.
Beverage companies are interested in marijuana because it gives them a chance to introduce an entirely new category of drinks to the consumer market.
Alcoholic beverage companies see marijuana as a potential threat. A study from the University of Connecticut and Georgia State University researchers found that alcohol sales dropped by 15% following the implementation of medical marijuana legalization in U.S. states. Legalization of recreational marijuana could affect alcoholic beverage makers even more, since a larger number of consumers could choose marijuana products in states with legalized recreational marijuana than in states allowing only legal medical marijuana.
For alcoholic beverage makers, launching cannabis-infused beverages is a way to offset potential lost sales from their core products. But these companies, as well as makers of non-alcoholic beverages, also could enjoy increased revenue from non-intoxicating CBD-infused beverages.
What to look for in marijuana beverage stocks
There are two major kinds of marijuana beverage stocks. First, there are marijuana stocks positioned to compete in the cannabis-infused-beverages market. Second, there are beverage stocks that seek to offer cannabis-infused beverages. What to look for before investing in one of these companies is basically the same for both categories, but with a twist for each one.
For pure-play marijuana stocks, one of the most important criteria is capacity. A company can only sell what it’s able to produce. Another key thing to look for with these stocks is its ability to target a large retail consumer market. Partnerships with companies that already have this expertise and that have retail distribution channels are a big plus. So is access to the capital required to compete in large retail markets that require significant advertising and promotional spending.
For beverage stocks, it’s also critical to possess the capability to successfully reach large retail consumer markets. As with pure-play marijuana stocks, that includes being able to fund large-scale marketing campaigns and having solid retail distribution channels. But beverage stocks also need a source for the cannabis ingredients needed for cannabis-infused drinks. That means they need partnerships with marijuana growers.
Investors should also use the criteria they’d use for investing in any kind of stock. Companies’ track records of success in their industry are important. And don’t forget the stock’s valuation — what the market thinks the stock is really worth. While it can be acceptable to pay a premium for a stock, the company’s realistic growth prospects need to justify that premium.
Top marijuana beverage stocks
With these criteria in mind, there are five top marijuana beverage stocks that investors should consider buying in 2019.
Data source: Yahoo! Finance. Market caps as of Dec. 15, 2018.
Canopy Growth is the world’s largest marijuana grower in terms of market cap — the total value of a company’s outstanding shares. The company boasts more than 4.3 million square feet of licensed growing space, making Canopy one of the two biggest marijuana producers in terms of annual production capacity.
Canopy has been a major supplier for Canada’s medical marijuana market for several years and is now one of the top suppliers for the country’s recreational marijuana market, with supply agreements in place with all of Canada’s provinces and territories. The company also has significant international operations in Europe, Latin America, Australia, and the Caribbean.
In 2017, major alcoholic beverage maker Constellation Brands and Canopy Growth formed a partnership to develop cannabis-infused beverages. As part of this deal, Constellation bought a 9.9% stake in Canopy. In August 2018, Constellation invested another $4 billion in Canopy Growth, increasing its ownership to 38%.
Canopy Growth shares initially traded only on the Toronto Stock Exchange. However, in May 2018 the stock also listed on the New York Stock Exchange, opening up a new opportunity for Canopy to raise capital. But thanks to its partnership with and the big investment from Constellation, Canopy doesn’t have to worry about issuing new shares to fund its planned entry into the marijuana beverage market.
Valuation metrics based on earnings, such as the price-to-earnings (P/E) ratio, can’t be used with Canopy Growth because the company isn’t yet consistently profitable. However, investors use the price-to-sales (P/S) ratio to value companies that aren’t profitable or aren’t consistently profitable.
Canopy’s P/S ratio of 150 is extremely high, however. Most stocks trade at P/S ratios in the low to mid-single digits. But Canopy’s P/S ratio is based on historical sales. The company’s high market cap reflects tremendous expectations of growth for the company as recreational and medical marijuana markets expand around the world.
Constellation Brands is the third-largest beer maker in the U.S., with its best-known products including Corona and Modelo. The company’s sales are growing faster than are those of its peers. Constellation also is the No. 1 high-end beer company and the No. 1 imported-beer company in the U.S., two of the most lucrative segments in the beer industry.
The company decided to move into the cannabis market because it saw a tremendous opportunity to build premium consumer brands similar to what it has done in the beer, wine, and spirits markets. With Canopy Growth, Constellation has a partner that is already a leader in the cannabis industry that has the capacity and scale to compete globally.
Constellation and Canopy plan to introduce a variety of cannabis-infused beverages in Canada when regulations are finalized. And Constellation is definitely preparing to enter the U.S. market as well, as soon as federal laws allow.
Although Constellation used a lot of its cash to fund the Canopy Growth transaction, the company continues to generate strong cash flow — with estimated free cash flow in fiscal 2019 of between $1.2 billion and $1.3 billion. Free cash flow, by the way, is the company’s cash generated from operations minus capital expenditures — money spent on fixed assets such as land, buildings, and equipment. It’s a great metric to use to determine the overall financial strength of a company. Constellation’s debt levels have decreased in recent years, giving it more financial flexibility.
Constellation stock’s valuation appears to be relatively attractive in comparison with most pure-play marijuana stocks. That’s largely because the company has an established track record of success, while marijuana stocks’ valuations are based more on future expectations. However, the company’s success in its core market makes its stock trade at a premium to its major peers in the alcoholic beverage industry.
Hexo, formerly known as Hydropothecary, is a lot smaller than Canopy Growth. But it’s currently the fourth largest Canadian marijuana producer in terms of capacity. Hexo is on track to produce 108,000 kilograms of cannabis annually by the end of 2018.
The company is most dominant in its home province of Quebec. In April, Hexo signed a supply agreement for Quebec’s recreational marijuana market that assures that the company will enjoy a market share of 35%. The deal was the largest forward-supply contract ever in the Canadian cannabis industry. Hexo also has supply channels in four other Canadian provinces.
Hexo filed a preliminary prospectus in November 2018 to “make offerings of up to $800 million [Canadian] of common shares, warrants, subscription receipts, and units or a combination thereof of the company from time to time.” This move, combined with its partnership with Molson Coors, should enable Hexo to make a big splash in the marijuana beverage market. And if Hexo’s sales increase enough from its Molson Coors partnership, it could drive the stock significantly higher — good news for shareholders.
Like Canopy Growth, Hexo isn’t yet profitable. Although Hexo has a lower market cap than Canopy, its stock trades at an even higher multiple of sales than Canopy does. That’s probably because investors think that as a smaller company, Hexo has more room to grow than Canopy does. Still, its solid position in Quebec and its Molson Coors relationship give Hexo a great shot at being a big winner in the marijuana beverages market.
Heineken is one of the world’s largest beermakers and sells more than 300 international, regional, local, and specialty beers and ciders. In terms of revenue generation, the company ranks second, behind only Anheuser-Busch InBev.
While Constellation Brands is waiting to launch a cannabis-infused beverage, Heineken beat it to the punch, having launched one in California’s, the world’s biggest marijuana market. In June 2018, Heineken subsidiary Lagunitas announced a partnership with cannabis company AbsoluteXtracts to market cannabis-infused sparkling water products under the brand name Hi-Fi Hops. The products became available to consumers in July 2018. One version of Hi-Fi Hops contains 10 mg of THC, while the other contains 5 mg of THC and 5 mg of CBD.
Funding major marketing campaigns isn’t a problem for Heineken at all. The company consistently generates a multibillion-dollar cash flow and has an ample cash stockpile.
Heineken stock is more attractively valued than Constellation Brands based on forward P/E ratios — which measures a stock price by its predicted earnings. This lower valuation is due primarily to Constellation’s stronger financial performance in recent years. Investors pay more for stocks that are perceived to be of a higher quality. With its Hi-Fi Hops products leaping off the shelves, the company reaped the rewards from its first-mover status in the U.S. among major beermakers hoping to cash in on the cannabis beverage market.
Aphria is the fourth largest Canadian marijuana stock by market cap. But the company is the No. 3 producer in terms of annual production capacity and should hold that position for at least a few more years. Aphria is on track to be able to grow 255,000 kilograms of cannabis per year.
Although Aphria doesn’t have a partnership at this point with an alcoholic beverage maker, it does have a close relationship with a key player in the alcoholic beverage industry. Aphria selected Southern Glazer’s, the largest wine and spirits distributor in North America, to distribute its recreational marijuana products in Canada.
Aphria has also been mentioned as a potential candidate for several beverage makers. In August, for example, reports surfaced that Diageo was in the hunt for a cannabis partner. Aphria was widely considered to be near the top of the list, especially considering its chief commercial officer was the president of Diageo Canada before joining Aphria.
In the meantime, Aphria formed a joint venture with retail strategy company Perennial to develop consumer-centric brands for cannabis-infused products, including, but not limited to, cannabis-infused drinks. The initial focus of this joint venture will be on cannabis-infused products for the wellness, medical, and recreational marijuana markets.
Aphria’s valuation is steep based on historical sales. However, the stock looks quite attractive in comparison with its key rivals, especially considering Aphria’s tremendous production capacity.
Risks for marijuana beverage stocks
There are two kinds of risks for marijuana beverage stocks of which investors should be especially aware — regulatory risks and valuation risks.
The main regulatory risk for businesses focused on the Canadian market is that the government won’t finalize regulations as quickly as expected. Delays could hurt stocks such as Canopy Growth, Constellation Brands, Hexo, and Aphria. Every month of delay is an additional month of missed sales, and more time that the capital spent developing these new products doesn’t pay off for shareholders.
In the U.S., there is a risk that the federal government could choose to enforce anti-marijuana laws in states that have legalized marijuana. While that risk appears to be lower than in the past, it’s still a looming possibility.
What are the valuation risks? The current valuations for many marijuana beverage stocks reflect expectations of tremendous growth. If this growth isn’t achieved, these stocks could be hit especially hard.
Investors seeking to reduce valuation risks will probably prefer stocks such as Constellation Brands. Most of the stock’s valuation is pegged to its core alcoholic beverage business, which is easier to project than the marijuana beverage business because there’s a long track record available. If the marijuana beverage play doesn’t pan out, at least you’re invested in a business that does strong alcohol sales.
Think long term
The key to success with investing in marijuana beverage stocks is the key to success in investing in any stock: Think long term. Buy stocks with an eye toward their growth potential over the next 10 years or more. Ideally, you should buy a stock with the idea of holding the stock for at least several years — although major changes to your assumptions that led you to buy the stock can warrant selling sooner.
There will inevitably be volatility over the short run with these stocks. However, the long-term trends definitely appear to be in their favor. As more countries allow cannabis-infused beverages to be sold, the stocks of the companies best positioned to profit from the growth should deliver nice returns to patient investors.
Take a sip of these stocks to profit from the burgeoning marijuana beverage market.